D.E. Shaw & Co’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
Other funds holding CLB
AI
DGI
CAMG
D.E. Shaw & Co's CLB Position: Q2 2026 in Review
D.E. Shaw & Co increased its Core Laboratories (CLB) stake by 109% in Q2 2026, buying an estimated $1.85M and bringing the position to 248,070 shares worth $2.89M. The position accounts for ﹤0.01% of the portfolio, ranked #2887.
D.E. Shaw & Co first reported a position in CLB in Q2 2013 and has held it in 44 quarters since. The position peaked at $12.8M in Q2 2014. 187 funds tracked by Wall St. Rank hold CLB as of Q2 2026.
- D.E. Shaw & Co held 248,070 shares of Core Laboratories worth $2.89M as of Q2 2026.
- D.E. Shaw & Co bought 129,644 Core Laboratories shares in Q2 2026, an estimated $1.85M.
- Core Laboratories made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q2 2026, its #2887 holding.
- D.E. Shaw & Co first reported a position in Core Laboratories in Q2 2013 and has held it in 44 quarters since.
- D.E. Shaw & Co's Core Laboratories position peaked at $12.8M in Q2 2014.
- 187 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2026.
Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.